Exciting data presented on Monday at the 2023 ACC Meeting in New Orleans. Dr. Joseph Lerman from Duke provides a summary of his presentation on the findings of a sub-study analysis from the GUARDIAN-Heart Registry showing improved post-transplant outcomes in patients on a durable LVAD undergoing a heart transplant using the Paragonix SherpaPak CTS. Note: I apologize for the background noise -- but it was a busy, well-attended conference! #acc23 #duke #wccardio
An exciting glimpse into the clinical research presented at ACC this week! This is the first GUARDIAN-Heart sub-study analysis on post-transplant outcomes that represents the vulnerable population group of patients on a durable LVAD. Congratulations to all involved in this promising research effort.